LI3
3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-YLBENZAMIDE
Find entries where: LI3
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-YLBENZAMIDE |
Identifiers | 3-fluoro-N-(1H-indol-5-yl)-5-morpholin-4-yl-benzamide |
Formula | C19 H18 F N3 O2 |
Molecular Weight | 339.364 |
Type | NON-POLYMER |
Isomeric SMILES | c1cc2c(cc[nH]2)cc1NC(=O)c3cc(cc(c3)F)N4CCOCC4 |
InChI | InChI=1S/C19H18FN3O2/c20-15-9-14(11-17(12-15)23-5-7-25-8-6-23)19(24)22-16-1-2-18-13(10-16)3-4-21-18/h1-4,9-12,21H,5-8H2,(H,22,24) |
InChIKey | VMLSXFMXUNVCSK-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 43 |
Chiral Atom Count | 0 |
Bond Count | 46 |
Aromatic Bond Count | 16 |
Drug Info: DrugBank
DrugBank ID | DB08092 |
---|---|
Name | 3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide |
Groups | experimental |
Description | 3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide is a solid. This compound belongs to the phenylmorpholines. These are aromatic compounds containing a morpholine ring and a benzene ring linked to each other through a CC or a CN bond. This drug targets mitogen-activated protein kinase 14. |
Synonyms | 3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Mitogen-activated protein kinase 14 | MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRV... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 5326870 |
ChEMBL | CHEMBL195450 |